A Phase 1 Trial to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of SHR-3167 Single Injection in Healthy Subjects and Patients With Type 2 Diabetes

T2DM Clinical Trial

Official title:
A Phase 1 Trial to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of SHR-3167 Single Injection in Healthy Subjects and Patients With Type 2 Diabetes

Status Recruiting

Clinical Trial Summary

This is a randomized, double-blind, placebo-controlled, single-dose escalation trial was designed. There are 6 dose groups and 1 optional dose group: 0.5 mg, 2 mg, 8 mg, 25mg, 50 mg, 100 mg and 150 mg (optional). Eight healthy adult subjects or T2DM patients in each dose group (except for 0.5 mg dose group, only 4 subjects will be enrolled) are randomly assigned to subcutaneously injection of SHR-3167 or placebo according to 3:1 ratio.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

T2DM

Clinical Trial Details

NCT number	NCT05996380
Study type	Interventional
Source	Jiangsu HengRui Medicine Co., Ltd.
Contact	Meng Sun
Phone	+86 18036618718
Email	meng.sun@hengrui.com
Status	Recruiting
Phase	Phase 1
Start date	June 9, 2023
Completion date	April 28, 2024

View Details

See also
Status	Clinical Trial	Phase
Not yet recruiting	`NCT04544319` - Clinical Trial to Compare the PK of the Fixed-dose Combinations and Each Component of Gemigliptin/Dapagliflozin 50/10 mg	Phase 1
Recruiting	`NCT02037100` - Sleep Disordered Breathing and Impaired Glucose Homeostasis in Obese Children	N/A
Recruiting	`NCT03563794` - Efficacy and Safety of Vildagliptin Added to Continuous Subcutaneous Insulin Infusion in Uncontrolled Type 2 Diabetes	Phase 4
Completed	`NCT01990469` - Efficacy and Safety of Gemigliptin 50mg qd Added in Patients With Type 2 Diabetes Inadequately Controlled on Glimepiride and Metformin	Phase 3
Active, not recruiting	`NCT05680129` - A Phase 3 Study to Evaluate the Efficacy of XW003 Compared With Dulaglutide in Participants With T2DM	Phase 3
Active, not recruiting	`NCT04609631` - Tai Chi for Comorbid Depression in T2DM Patients	N/A
Completed	`NCT05681273` - Drug-Drug Interaction Study of Chiglitazar in Healthy Subjects.	Phase 1
Active, not recruiting	`NCT05680155` - A Phase 3 Study to Evaluate the Efficacy of XW003 Compared With Placebo in T2DM Patients	Phase 3
Recruiting	`NCT03564431` - The Imaging Genetic Study of Type 2 Diabetes and Depression
Recruiting	`NCT05159882` - Safety and Efficacy of THR-1442 Compared to Dapagliflozin as Add-on Therapy to Metformin in T2DM	Phase 3